Dr. David William Goetz, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1063 Maple Dr, Suite 1a, Morgantown, WV 26505 Phone: 304-598-2992 Fax: 304-598-5901 |
Dr. William Thomas Corder, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 165 Scott Ave, Suite 102, Morgantown, WV 26508 Phone: 304-554-0440 Fax: 304-624-0026 |
Dr. Steven Walter Coutras, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Morgantown, WV 26506 Phone: 304-293-3457 |
News Archive
Weight loss, regular physical activity and other lifestyle changes are effective yet underused strategies that should be added to optimize management of atrial fibrillation (an abnormal heart rhythm), according to "Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation," a new Scientific Statement from the American Heart Association published today in the Association's flagship journal Circulation.
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, announced the issuance of patents in the US and Europe that provide additional coverage for its SHM-XEL platform. These patents extend AnaptysBio's leadership in the use of somatic hypermutation (SHM) for the discovery and optimization of antibodies and other proteins.
Umbilical cords of children whose mothers used selective serotonin reuptake inhibitors during pregnancy may be longer than umbilical cords of other newborn children, shows a new study from the University of Eastern Finland and Kuopio University Hospital. Selective serotonin reuptake inhibitors, SSRIs, are commonly prescribed antidepressants, and this is the first time their association with umbilical cord length was observed.
To ignite a life-threatening infection in the body, a virus such as HIV invades body cells by first merging, or fusing, with the cell's outer membrane. Once inside the cell, the invading microbe's genetic material takes over, turning the 'host' cell into a factory to produce more copies of the virus, which then spill out to invade other cells in the body.
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals today announced TPI has received the production license for its anti-diabetic drug Gliclazide Tablets from China's State Food and Drug Administration.
› Verified 5 days ago